From Data to Discovery, Faster

The world’s leading bioinformatics software platform

Involved in therapeutic antibody R&D? Geneious Biologics screens and manages antibody sequence data in the cloud, transforming data management and significantly speeding up candidate selection. Learn more >

We make it easy

The user-friendly analysis and management tools in Geneious Prime help unlock the value in sequence data.

Painfree analysis with an intuitive, user-friendly interface

Increase process efficiency and improve data organisation

Cross-platform: Mac, Windows, Linux

Comprehensive support for technical issues, set up and training

“I have found Geneious to be one of the most intuitive and powerful sequence analysis programs that I have used in all my years working in the molecular biology field. Thanks for making my life so much easier.”

– Prof. John Payne, University of California

View Resources

Everything you need, all in one place

Geneious Prime is a powerful bioinformatics software solution packed with fundamental molecular biology and sequence analysis tools

Molecular Cloning & Primer Design

Perform a wide-range of cloning and primer design operations within one interface.

NGS Analysis and Genomics

Take charge with industry-leading assembly and mapping algorithms, and superior visualizations.

Shared Database

Manage and store data effectively and get teams collaborating efficiently.

Import and Export Data

Import, export and convert common file types as well as their annotations and notes.

Workflows

Save time and ensure your work is repeatable by creating or using in-built workflows.

API and Plugin Development

Integrate crucial operations using Geneious Prime’s API and Plugin Development tools.

“Geneious is an absolutely beautiful package to work with. We love it and we are telling everyone about it.”

– Charles Moore, Novartis Pharma AG, Switzerland

View Features

A History of Helping Scientists Innovate

“We created Geneious tools because we didn’t want our bright scientific minds spending 80 percent of their time doing basic data management. So we thought, if we can take away the pain and complexity of data computation and allow them to focus on what they’re really good at – which is understanding what that data means to uncover new scientific knowledge – then we’ve done our job.”

— Brett Ammundsen, Chief Executive Officer
About